Cargando…

Shiga Toxin 2 Triggers C3a-Dependent Glomerular and Tubular Injury through Mitochondrial Dysfunction in Hemolytic Uremic Syndrome

Shiga toxin (Stx)-producing Escherichia coli is the predominant offending agent of post-diarrheal hemolytic uremic syndrome (HUS), a rare disorder of microvascular thrombosis and acute kidney injury possibly leading to long-term renal sequelae. We previously showed that C3a has a critical role in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buelli, Simona, Locatelli, Monica, Carminati, Claudia Elisa, Corna, Daniela, Cerullo, Domenico, Imberti, Barbara, Perico, Luca, Brigotti, Maurizio, Abbate, Mauro, Zoja, Carlamaria, Benigni, Ariela, Remuzzi, Giuseppe, Morigi, Marina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179250/ https://www.ncbi.nlm.nih.gov/pubmed/35681450 http://dx.doi.org/10.3390/cells11111755

Ejemplares similares

Complement Activation Contributes to the Pathophysiology of Shiga Toxin-Associated Hemolytic Uremic Syndrome
por: Buelli, Simona, et al.
Publicado: (2019)

Low Nephron Number Induced by Maternal Protein Restriction Is Prevented by Nicotinamide Riboside Supplementation Depending on Sirtuin 3 Activation
por: Pezzotta, Anna, et al.
Publicado: (2022)

A previously unrecognized role of C3a in proteinuric progressive nephropathy
por: Morigi, Marina, et al.
Publicado: (2016)

Add-On Cyclic Angiotensin-(1-7) with Cyclophosphamide Arrests Progressive Kidney Disease in Rats with ANCA Associated Glomerulonephritis
por: Cerullo, Domenico, et al.
Publicado: (2022)

SARS-CoV-2 spike protein induces lung endothelial cell dysfunction and thrombo-inflammation depending on the C3a/C3a receptor signalling
por: Perico, Luca, et al.
Publicado: (2023)

Sirtuin 3 Deficiency Aggravates Kidney Disease in Response to High-Fat Diet through Lipotoxicity-Induced Mitochondrial Damage
por: Locatelli, Monica, et al.
Publicado: (2022)

Renal Primordia Activate Kidney Regenerative Events in a Rat Model of Progressive Renal Disease
por: Imberti, Barbara, et al.
Publicado: (2015)

Endothelial Glycocalyx of Peritubular Capillaries in Experimental Diabetic Nephropathy: A Target of ACE Inhibitor-Induced Kidney Microvascular Protection
por: Locatelli, Monica, et al.
Publicado: (2023)

Sirt3 deficiency promotes endothelial dysfunction and aggravates renal injury
por: Pezzotta, Anna, et al.
Publicado: (2023)

Protective Effects of Human Nonrenal and Renal Stromal Cells and Their Conditioned Media in a Rat Model of Chronic Kidney Disease
por: Imberti, Barbara, et al.
Publicado: (2020)

Mitochondrial-dependent Autoimmunity in Membranous Nephropathy of IgG4-related Disease
por: Buelli, Simona, et al.
Publicado: (2015)

Manipulating Sirtuin 3 pathway ameliorates renal damage in experimental diabetes
por: Locatelli, Monica, et al.
Publicado: (2020)

Post-translational modifications by SIRT3 de-2-hydroxyisobutyrylase activity regulate glycolysis and enable nephrogenesis
por: Perico, Luca, et al.
Publicado: (2021)

Renal Expression of FGF23 in Progressive Renal Disease of Diabetes and the Effect of Ace Inhibitor
por: Zanchi, Cristina, et al.
Publicado: (2013)

Sirtuin3 Dysfunction Is the Key Determinant of Skeletal Muscle Insulin Resistance by Angiotensin II
por: Macconi, Daniela, et al.
Publicado: (2015)

Potential of mesenchymal stem cells in the repair of tubular injury
por: Imberti, Barbara, et al.
Publicado: (2011)

Therapeutic potential of stromal cells of non-renal or renal origin in experimental chronic kidney disease
por: Rota, Cinzia, et al.
Publicado: (2018)

Human mesenchymal stromal cells transplanted into mice stimulate renal tubular cells and enhance mitochondrial function
por: Perico, Luca, et al.
Publicado: (2017)

Thyroid hormone treatment counteracts cellular phenotypical remodeling in diabetic organs
por: Lavecchia, Angelo M., et al.
Publicado: (2023)

SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation
por: Perico, Luca, et al.
Publicado: (2022)

Sirtuin 3 in acute kidney injury
por: Perico, Luca, et al.
Publicado: (2015)

SARS-CoV-2 and the spike protein in endotheliopathy
por: Perico, Luca, et al.
Publicado: (2023)

Turnour necrosis factor stimulates endothelin-1 gene expression in cultured bovine endothelial cells
por: Orisio, Silvia, et al.
Publicado: (1992)

CFH and CFHR structural variants in atypical Hemolytic Uremic Syndrome: Prevalence, genomic characterization and impact on outcome
por: Piras, Rossella, et al.
Publicado: (2023)

MicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathy
por: Zanchi, Cristina, et al.
Publicado: (2017)

Shiga Toxins and the Pathophysiology of Hemolytic Uremic Syndrome in Humans and Animals
por: Mayer, Chad L., et al.
Publicado: (2012)

Shiga toxin-associated hemolytic uremic syndrome complicated by intestinal perforation in a child with typical hemolytic uremic syndrome
por: Chang, Hye Jin, et al.
Publicado: (2014)

Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)
por: Scheiring, Johanna, et al.
Publicado: (2008)

Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review
por: Joseph, Adrien, et al.
Publicado: (2020)

Glomerular Diseases Dependent on Complement Activation, Including Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, and C3 Glomerulopathy: Core Curriculum 2015
por: Noris, Marina, et al.
Publicado: (2015)

Shiga Toxin-Mediated Hemolytic Uremic Syndrome: Time to Change the Diagnostic Paradigm?
por: Bielaszewska, Martina, et al.
Publicado: (2007)

New insights into Shiga toxin-mediated endothelial dysfunction in hemolytic uremic syndrome
por: Petruzziello-Pellegrini, Tania N, et al.
Publicado: (2013)

Shiga Toxin–Associated Hemolytic Uremic Syndrome in Adults, France, 2009–2017
por: Travert, Benoît, et al.
Publicado: (2021)

Hemolytic uremic syndrome with simultaneous Shiga toxin producing Escherichia coli and complement abnormalities
por: McCoy, Nicole, et al.
Publicado: (2014)

Epidemiology and Characterization of Shiga Toxin-Producing Escherichia Coli of Hemolytic Uremic Syndrome in Argentina
por: Torti, Jeronimo F, et al.
Publicado: (2021)

Diagnosis and Treatment for Shiga Toxin-Producing Escherichia coli Associated Hemolytic Uremic Syndrome
por: Liu, Yang, et al.
Publicado: (2022)

Molecular Studies and an ex vivo Complement Assay on Endothelium Highlight the Genetic Complexity of Atypical Hemolytic Uremic Syndrome: The Case of a Pedigree With a Null CD46 Variant
por: Piras, Rossella, et al.
Publicado: (2020)

Combined Action of Shiga Toxin Type 2 and Subtilase Cytotoxin in the Pathogenesis of Hemolytic Uremic Syndrome
por: Álvarez, Romina S., et al.
Publicado: (2021)

Hemoconcentration and predictors in Shiga toxin-producing E. coli-hemolytic uremic syndrome (STEC-HUS)
por: Loos, Sebastian, et al.
Publicado: (2021)

Early and late scanning electron microscopy findings in diabetic kidney disease
por: Conti, Sara, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bbqsumpt0cf80cuhd2mn44g86a